Innovation

SYNOPSIS

A team of French scientists has developed a potential HIV/AIDS vaccine, using a protein of the HIV-virus called 'GP41'. It allows the generation of neutralising antibodies and could in turn help overcome one of the world’s most pernicious diseases.